Omkar Speciality Chemicals Issues Clarification on Record Date for April 15 Meeting
Omkar Speciality Chemicals issued a clarificatory intimation regarding its April 15, 2026 monitoring committee meeting, stating that this date will not serve as the record date. The company will fix a revised record date during the meeting with mandatory 7 working days gap compliance, while proceeding with planned equity restructuring and new share issuance worth INR 5,00,00,000.

*this image is generated using AI for illustrative purposes only.
Omkar Speciality Chemicals Limited has issued a clarificatory intimation regarding its monitoring committee meeting scheduled for April 15, 2026, addressing important revisions to the previously announced record date arrangements. The company, which entered Corporate Insolvency Resolution Process (CIRP) on December 5, 2022, provided this update to ensure regulatory compliance under SEBI listing obligations.
Record Date Clarification
In a formal communication dated April 14, 2026, the company clarified two critical points regarding the upcoming monitoring committee meeting:
| Clarification: | Details |
|---|---|
| Original Assumption: | April 15, 2026 was not intended as record date |
| Revised Process: | Record date to be fixed during the meeting |
| Compliance Requirement: | Minimum 7 working days gap from meeting date |
| Communication Method: | Outcome to be intimated via stock exchange |
Meeting Agenda and Restructuring Plans
The monitoring committee meeting will address several critical corporate restructuring matters under the supervision of Chairperson Mr. Ajit Kumar, the erstwhile Resolution Professional. The committee will consider multiple significant proposals that reflect the company's ongoing restructuring process under the approved resolution plan.
Equity Share Restructuring
The committee will determine record dates for extinguishment and cancellation of existing equity shares in accordance with the approved scheme:
| Share Category: | Details |
|---|---|
| Promoter Shares: | Entire equity shares of INR 10.00 each, fully paid up |
| Public Shareholder Shares: | Entire equity shares of INR 10.00 each, fully paid up |
| Action: | Complete extinguishment/cancellation |
New Share Issuance
A major agenda item involves approving the issuance of new equity shares under the resolution plan:
| Parameter: | Details |
|---|---|
| Number of Shares: | 50,00,000 equity shares |
| Face Value: | INR 10.00 each |
| Issue Price: | At par |
| Total Consideration: | INR 5,00,00,000 |
| Issuance Method: | Private Placement Basis |
Key Appointments and Operational Matters
The committee will consider appointing key management personnel to strengthen the company's operational framework:
| Position: | Appointee Details |
|---|---|
| Chief Financial Officer: | Mr. Mahendra Kumar Jain (PAN: AYHPJ9945Q) |
| Company Secretary & Compliance Officer: | Mr. Kuldeep Menaria (Membership No. ACS: 68041) |
The meeting will also address borrowing arrangements through loan agreements without conversion options into securities, along with reviewing statutory and contractual compliances and adjustment of CIRP costs.
Corporate Background
Omkar Speciality Chemicals Limited, incorporated with CIN L24110MH2005PLC151589, is registered in Badlapur, Maharashtra. The company entered CIRP through an order dated December 5, 2022, under case IA 1521/2022 In C.P. (IB)/1738(MB)2017. The monitoring committee is chaired by Mr. Ajit Kumar, who continues to oversee the company's restructuring process from his office at Ocus Quantum, Sector 51, Gurugram.
What impact will the complete extinguishment of existing equity shares have on current shareholders' ownership rights and potential compensation?
How will the private placement of 50 lakh new equity shares at par value affect the company's ownership structure and control dynamics?
What are the expected timelines for Omkar Speciality Chemicals to exit the CIRP process and resume normal business operations?

























